The Clot Thickens: New Opportunities for Thrombosis Mitigation and Stroke Prevention in Atrial Fibrillation-A Landscape Change in Cardiovascular Medicine? Peter Libby, MD, FACC
Challenges and Emerging Dimensions of Stroke Prevention in the Setting of Atrial Fibrillation (AF): Achieving the Ideal Balance Between Thromboprophylaxis and Bleeding Reduction Jonathan L. Halperin, MD
Stroke Prevention in High Risk Populations: Making the Best of Warfarin Therapy—Optimizing Time in Therapeutic Range (TTR) and Strategies for Keeping Warfarin Relevant in AF Elaine M. Hylek, MD, MPH
The Emerging Role of Direct Thrombin and Factor Xa Inhibition in Cardiovascular Medicine: Mechanisms, Trials, and Applications for Thrombosis Mitigation Across the CV Disease Spectrum Jeffrey I. Weitz, MD, FRCP, FACP
Summary and Conclusions Peter Libby, MD, FACC
Question and Answer Session Faculty Panel
